Antibacterial action of synthetic antilipopolysaccharide peptides (SALP) involves neutralization of both membrane‐bound and free toxins

Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis

(2018) Evelina Tacconelli et al.   LANCET INFECTIOUS DISEASES

Therapeutical Administration of Peptide Pep19-2.5 and Ibuprofen Reduces Inflammation and Prevents Lethal Sepsis

(2015) Lena Heinbockel et al.   PLoS One

Lipoproteins/peptides are sepsis-inducing toxins from bacteria that can be neutralized by synthetic anti-endotoxin peptides

(2015) Guillermo Martinez de Tejada et al.   Scientific Reports

Intestinal mucus affinity and biological activity of an orally administered antibacterial and anti-inflammatory peptide

(2014) Aline Dupont et al.   GUT

Structural basis for lipopolysaccharide insertion in the bacterial outer membrane

(2014) Shuai Qiao et al.   NATURE

Preclinical Investigations Reveal the Broad-Spectrum Neutralizing Activity of Peptide Pep19-2.5 on Bacterial Pathogenicity Factors

(2013) Lena Heinbockel et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Biophysical Mechanisms of Endotoxin Neutralization by Cationic Amphiphilic Peptides

(2011) Yani Kaconis et al.   BIOPHYSICAL JOURNAL

Optimizing Optical Flow Cytometry for Cell Volume-Based Sorting and Analysis

(2011) Amit Tzur et al.   PLoS One

New Antiseptic Peptides To Protect against Endotoxin-Mediated Shock

(2010) T. Gutsmann et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Damage of the Bacterial Cell Envelope by Antimicrobial Peptides Gramicidin S and PGLa as Revealed by Transmission and Scanning Electron Microscopy

(2010) M. Hartmann et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Bacterial Cell Envelope

(2010) T. J. Silhavy et al.   Cold Spring Harbor Perspectives in Biology